Affiliation:
1. China-Japan Friendship Clinical Medical Research Institute
2. China-Japan Friendship Hospital
3. Peking University Third Hospital
Abstract
Abstract
Objective
To investigate the correlation of neutrophil-to-lymphocyte ratios (NLR) with prognosis of stage I non-small cell lung cancer (NSCLC).
Methods.
Clinical data from 567 stage I NSCLC patients who received surgical treatment in our hospital from May 2007 to May 2014 were analyzed retrospectively. According to preoperative peripheral blood NLR values, patients were divided into low- and high-NLR groups. Univariate and multivariate survival analyses were performed to evaluate the correlation of preoperative NLRs with postoperative survival.
Results.
NLRs ranged from 0.48 to 47.25 (median 2.19). The five-year survival for patients in the high-NLR (NLR > 2.19) and low-NLR (NLR < 2.19) groups were 75.7% and 87.3%, respectively, showing significant difference (P = 0.004). Univariate analysis confirmed that age, gender, smoking history, histological tumor type and tumor size, vascular and visceral pleural invasion, and NLRs were prognostic factors for stage I NSCLC. Cox multivariate regression analysis revealed that age, gender, tumor size, vascular and visceral pleural invasion, and NLRs were independent prognostic risk factors for stage I NSCLC.
Conclusion.
NLR may be an independent prognostic factor for stage I NSCLC and elevated NLR is associated with poor prognosis.
Publisher
Research Square Platform LLC
Reference28 articles.
1. A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours;Paramanathan A;Surg Oncol,2014
2. Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: a systemic review and meta-analysis;Peng B;Int J Clin Exp Med,2015
3. Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis;Yin Y;Clinics,2015
4. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer;Lardinois D;Eur J Cardiothorac Surg,2006
5. Vallieres E, Shepherd FA, Crowley J. el al. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol, 2009, 4(9):1049–1059.